SENSIPAR Trademark

Trademark Overview

On Friday, January 26, 2001, a trademark application was filed for SENSIPAR with the United States Patent and Trademark Office. The USPTO has given the SENSIPAR trademark a serial number of 76200460. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, September 4, 2024. This trademark is owned by Amgen Inc.. The SENSIPAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia
sensipar

General Information

Serial Number76200460
Word MarkSENSIPAR
Filing DateFriday, January 26, 2001
Status800 - REGISTERED AND RENEWED
Status DateWednesday, September 4, 2024
Registration Number2867132
Registration DateTuesday, July 27, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 2, 2001

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 9, 2001
Primary Code005
First Use Anywhere DateTuesday, April 6, 2004
First Use In Commerce DateTuesday, April 6, 2004

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Friday, May 18, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 2, 2001PUBLISHED FOR OPPOSITION
Tuesday, May 8, 2001ASSIGNED TO EXAMINER
Monday, May 14, 2001EXAMINER'S AMENDMENT MAILED
Wednesday, September 12, 2001NOTICE OF PUBLICATION
Monday, May 13, 2002SOU EXTENSION 1 GRANTED
Wednesday, June 11, 2003SOU EXTENSION 3 GRANTED
Tuesday, December 25, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2002PAPER RECEIVED
Tuesday, April 30, 2002SOU EXTENSION 1 FILED
Wednesday, November 13, 2002PAPER RECEIVED
Wednesday, November 13, 2002SOU EXTENSION 2 FILED
Tuesday, January 28, 2003SOU EXTENSION 2 GRANTED
Monday, May 5, 2003PAPER RECEIVED
Monday, May 5, 2003SOU EXTENSION 3 FILED
Wednesday, December 10, 2003SOU EXTENSION 4 FILED
Tuesday, December 23, 2003SOU EXTENSION 4 GRANTED
Friday, April 16, 2004USE AMENDMENT FILED
Thursday, April 29, 2004CASE FILE IN TICRS
Wednesday, May 5, 2004STATEMENT OF USE PROCESSING COMPLETE
Friday, May 7, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 27, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, June 8, 2010TEAS SECTION 8 & 15 RECEIVED
Friday, June 25, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 30, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 10, 2003SOU TEAS EXTENSION RECEIVED
Friday, April 23, 2004TEAS STATEMENT OF USE RECEIVED
Friday, May 7, 2004ASSIGNED TO EXAMINER
Friday, February 7, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 7, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 21, 2014TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 21, 2014REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, February 7, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, February 7, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, April 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 27, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 12, 2024TEAS SECTION 8 & 9 RECEIVED
Friday, July 12, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, September 4, 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, July 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 11, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, September 4, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

sensipar bloodstream treatment hyperparathyroidism hypercalcemia calcium level products namely pharmaceuticals modulating